Current Edition

Draft Guidance Addresses Inclusion of Adolescents in Oncology Trials

With an eye toward helping industry, investigators, and institutional review boards (IRBs), the US Food and Drug Administration (FDA) has unveiled draft guidance on the inclusion of adolescents in adult oncology trials. Elizabeth Hollis of Clarivate Analytics reveals in this article the importance of that as it is estimated that about 5000 US teens between the ages of 15 and 19 are diagnosed with cancer each year.